Contactless biometric ID verification kiosks improve distribution of restricted products

Dispension Industries Inc., a Dartmouth, Nova Scotia-based provider of an SaaS application for controlled substance or restricted product distribution systems, and ePortID LLC, a provider of contactless biometric identity verification solutions, have partnered to transform the distribution of restricted products using palm vein biometric identity verification technology in tandem with unattended self-service kiosks, according to a press release. This partnership combines Dispension's thought leadership in automated distribution of restricted products with ePortID's expertise in biometric access control solutions.

The solution is designed to improve the distribution of products that require identity verification such as pharmaceuticals, alcohol, cannabis, psychedelics, nicotine/vaping and lottery products. Identity verification by human personnel is costly and often unreliable since human ID checks can be scammed or faked, and unsafe due to the potential for exposure and transmission of infectious diseases such as COVID-19.

The integrated biometric access control technology allows the kiosks to effectively identify a person at the point of distribution in an unattended and contactless way. The solution improves security, prevents theft, captures direct consumer data, reduces operating costs and protects frontline workers and customers.

Rather than identifying someone with a bank card, ePortID's technology identifies people by the internal vein patterns in the palms of their hands.

Dispension's kiosks, equipped with ePortID's palm vein scanning access control system, are being used by the MySafe Society in a harm reduction initiative to reduce overdose deaths caused by street drugs in Canada. The kiosks distribute prescription opioids to registered users who suffer from substance use disorder and have a dependency on fentanyl contaminated street drugs that can cause fatal overdoses.

Source: Kiosk Marketplace